Cite

MLA Citation

    E Felip et al.. “LBA57Overall survival results of ceritinib in ALKi-naïve patients with ALK-rearranged NSCLC (ASCEND-3).” Annals of oncology, vol. 29, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100095518429.0x00002f
  
Back to record